InvestorsHub Logo
Followers 43
Posts 4900
Boards Moderated 0
Alias Born 04/30/2005

Re: Bourbon_on_my_cornflakes post# 359896

Tuesday, 05/10/2022 3:11:33 PM

Tuesday, May 10, 2022 3:11:33 PM

Post# of 463445
After the initial study for the P2 PDD trial was finished and TLDR was announced, I'm sure the FDA and Anavex wanted to see the longterm (48-week) results of the PDD OLE before starting a P3 trial...which could be pivotal.

Why spend all the time and money recruiting patients for a P3 trial when the OLE data won't be finished until June, 2022?

That's only one more month!

ANAVEX 2-73-PDD-EP-001 (NCT04575259)


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News